UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-kappa B Inhibition Journal article
Zou, Zheng-Qiang, Chen, Jia-Jia, Feng, Hong-Fang, Cheng, Yu-Fang, Wang, Hai-Tao, Zhou, Zhong-Zhen, Guo, Hai-Biao, Zheng, Wenhua, Xu, Jiang-Ping. Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-kappa B Inhibition[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362(1), 67-77.
Authors:  Zou, Zheng-Qiang;  Chen, Jia-Jia;  Feng, Hong-Fang;  Cheng, Yu-Fang;  Wang, Hai-Tao; et al.
Favorite | TC[WOS]:37 TC[Scopus]:40  IF:3.1/3.3 | Submit date:2018/10/30